Shuttle Pharmaceuticals Holdings (SHPH) Operating Leases (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Operating Leases history runs 6 years deep, the most recent figure standing at $214013.0 for Q1 2026.

• In Q1 2026, Operating Leases fell 24.47% year-over-year to $214013.0; the TTM figure through Mar 2026 stood at $214013.0 (down 24.47% YoY), while the FY2025 annual figure was $154953.0, down 34.92% from the prior year.
• Operating Leases was $214013.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $154953.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $329774.0 in Q2 2023 to a low of $6671.0 in Q3 2022.
• Historically, Operating Leases has averaged $217271.5 across 5 years, with a median of $267025.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Operating Leases tumbled 51.44% in 2022, then jumped 4523.37% in 2023.
• A 5-year view of Operating Leases shows it stood at $62823.0 in 2022, then surged by 384.1% to $304127.0 in 2023, then fell by 21.71% to $238088.0 in 2024, then tumbled by 34.92% to $154953.0 in 2025, then soared by 38.11% to $214013.0 in 2026.
• The last three Operating Leases figures came in at $214013.0 (Q1 2026), $154953.0 (Q4 2025), and $175318.0 (Q3 2025), per Business Quant data.